期刊文献+

五味子煎剂对2型糖尿病患者血清IL-2及IL-6水平的影响 被引量:8

Effects of Fructus Schisandrae Decoction on the Changes of Serum IL-2 and IL-6 of Patients with Type 2 Diabetes
原文传递
导出
摘要 目的:探讨五味子煎剂对2型糖尿病患者的临床疗效及血清IL-2、IL-6水平的影响。方法:选取我科门诊及住院的2型糖尿病病患者88例,随机分为两组,其中对照组44例,予盐酸二甲双胍胶囊常规治疗,1个月为一个疗程,治疗三个疗程;实验组44例,在常规治疗的基础上加用五味子15 g,日一剂水煎服,1个月为一个疗程,治疗三个疗程。治疗结束后,对比临床疗效及治疗前后患者IL-2、IL-6水平、糖化血红蛋白(Hb A1c)及血脂(TC、TG及LDL)。结果:治疗后两组患者IL-2明显升高,IL-6水平明显降低,差异具有统计学意义(P<0.05),且实验组IL-2、IL-6水平较对照组明显好转,差异有统计学意义(P<0.05);治疗后两组患者Hb A1c均有所降低,且实验组Hb A1c较对照组明显下降,差异有统计学意义(P<0.05);治疗后两组患者血脂均有所改善,且实验组血脂较对照组明显好转,差异有统计学意义(P<0.05)。结论:中药五味子能明显提高T2DM患者血清IL-2水平、降低IL-6水平,降低患者糖化血红蛋白及血脂水平,提高2型糖尿病临床疗效,对临床具有指导意义。 Objective: To investigate the clinical curative effect of Fructus Schisandrae Decoction on type 2 diabetes mellitus (T2DM) disease and the changes of serum IL-2, IL-6 levels. Methods: 88 patients with type 2 diabetic patients from our hospital were randomly divided into two groups, 44 patients in control group received routine treatment, Metformin Hydrochloride Capsules, 1 months for a course, three courses of treatment; 44 cases in the experimental group, that were given Schisandra chinensis 15g, Japan a dose of de- coot with water, 1 months for a course, three courses of treatment based on the conventional treatment. After the end of treatment, the level of IL-2 and IL-6 levels, glycosylated hemoglobin (HbAlc) and blood lipid (TC, TG and LDL) were compared before and after the treat- ments between two groups.' Results: After treatment, the cytokines were improved in both two groups, and the cytokines in the experi- mental group were improved more significantly than that of control group, the difference was statistically significant (P〈0.05); In the two groups after treatment, HbAlc were reduced, and the level of HbAlc in the experimental group were decreased more significantly than the control group, the difference was statistically significant (P〈0.05); In the two groups after treatment the level of blood lipid were im- proved, and it was more obviously in the experimental group than the control group, the difference was statistically significant (P〈0.05). Conclusions: Traditional Chinese medicine Schisandra can significantly improve the level of serum IL-2 in patients with type 2 diabetes, reduce the level of IL-6, reduce glycated hemoglobin and blood lipid level, improve clinical curative effect.
出处 《现代生物医学进展》 CAS 2015年第21期4084-4086,4131,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金面上项目(80772707)
关键词 2型糖尿病病 五味子煎剂 IL-2 IL-6 糖化血红蛋白 Type Ⅱ diabetes Schisandra Decoction IL-2, IL-6 Cytokines Glycated hemoglobin
  • 相关文献

参考文献20

  • 1Wang JY, Lee SH, Lee IT. Effect of prescription refill on quality ofcare among patients with type 2 diabetes: an exploratory study[J]. Di-abetes research and clinical practice, 2014,105(1): 110-118.
  • 2Wang SY, Chuang CS, Muo CH. Metformin and the incidence of can-cer in patients with diabetes: a nested case-control study [J]. Diabetescare, 2013, 36(9): el55-156.
  • 3Chang CH, Lin JW, Wu LC. Oral insulin secretagogues, insulin, andcancer risk in type 2 diabetes mellitus [J]. The Journal of clinical en-docrinology and metabolism, 2012, 97 (7): El 170-1175.
  • 4Chang CH, Lin JW, Wu LC. Association of thiazolidinediones withliver cancer and colorectal cancer in type 2 diabetes mellitus[J]. Hepa-tology (Baltimore, Md.), 2012, 55(5): 1462-1472.
  • 5Mu PW, Chen YM,Lu HY. Effects of a combination of oral anti-dia-betes drugs with basal insulin therapy on p'cell function and gly-caemic control in patients with newly diagnosedtype 2 diabetes [J].Diabetes/metabolism research and reviews, 2012,28(3): 236-240.
  • 6Lin SD, Wang JS, Hsu SR. The beneficial effect of a-glucosidase in-hibitor on glucose variability compared with sulfonylurea in Tai-wanese type 2 diabetic patients inadequately controlled with met-formin: preliminary data[J]. Journal of diabetes and its complications,2011,25(5): 332-338.
  • 7Chang CH, Lin JW, Wu LC. Angiotensin receptor blockade and risk ofcancer in type 2 diabetes mellitus: a nationwide case-control study[J].Journal of clinical oncology, 2011,29(22): 3001-3007.
  • 8Kabeya Y, Tomita M,Asai Y. Determinants of an optimal response topioglitazone in terms ofHDL-cholesterol[J]. Internal medicine (Tokyo,Japan), 2011,50(8): 825-831.
  • 9Chen SJ, Jiaang WT. Current advances and therapeutic potential ofagents targeting dipeptidyl peptidases-IV, -II, 8/9 and fibroblast acti-vation protein [J]. Current topics in medicinal chemistry, 2011, 11(12): 1447-1463.
  • 10Huang Q, Yin JY, Dai XP. Association analysis of SLC30A8rsl3266634 and rsl6889462 polymorphisms with type 2 diabetesmellitus and repaglinide response in Chinesepatients [J]. Europeanjournal of clinical pharmacology, 2010,66(12): 1207-1215.

同被引文献113

引证文献8

二级引证文献217

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部